The biopharmaceutical industry invests more of its revenue in generating new knowledge through research and development than other sectors

Note: Data relate to the top 2,500 companies with registered offices in the EU (590), Japan (356), the US (837), China (327) and the Rest of the World (390), ranked by total worldwide R&D investment (with investment in R&D above € 21 million).

Source: The 2016 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD